NeoGenomics to acquire Genoptix

Genoptix was founded in 1999, went public in 2007 and in 2011 was acquired by Novartis AG (NYSE:NVS; SIX:NOVN). Ampersand Capital Partners and 1315 Capital acquired the company from Novartis in 2017....